Cytogenetic abnormalities and associated efficacy from a phase III study comparing alemtuzumab vs. chlorambucilas first line therapy for B-cell chronic lymphocytic leukemia

被引：0
|
作者：
Robak, T.
Skotnicki, A.
Dmoszynska, A.
Hebert, J.
Wang, Y.
Belkaci, M.
Sirard, C.
Mayer, J.
Hillmen, P.
机构：
[1] Kopernik Mem Hosp, Lodz, Poland
[2] Jagiellonian Univ, Coll Med, Krakow, Poland
[3] Clin Hosp No 1, Lublin, Poland
[4] Cirion BioPharma Res Inc, Laval, PQ, Canada
[5] Genzyme, Cambridge, MA USA
[6] Univ Hosp Brno, Brno, Czech Republic
[7] Leeds Gen Infirm, Leeds, W Yorkshire, England
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0128
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [31] A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia
    Flowers, Christopher R.
    Brown, Jennifer R.
    Rosenthal, Hilary
    Stock, Wendy
    Katzen, Harvey I.
    Cohen, Jonathon B.
    Sinha, Rajni
    Lakhanpal, Shailendra
    Leis, Jose F.
    Waller, Edmund K.
    Jaye, David L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (11): : 694 - 698
  • [32] Alemtuzumab (CAMPATH®,MABCAMPATH®) has superior progression free survival (PFS) vs chlorambucil as front-line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL).
    Hillmen, Peter
    Skotnicki, Aleksander
    Robak, Tadeusz
    Jaksic, Branimir
    Sirard, Cynthia
    Mayer, Jiri
    BLOOD, 2006, 108 (11) : 93A - 93A
  • [33] Familial B-cell chronic lymphocytic leukemia - Analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage
    Aoun, Patricia
    Zhou, Guimei
    Chan, Wing C.
    Page, Cynthia
    Neth, Kellie
    Pickering, Diane
    Sanger, Warren
    Quinn-Laquer, Brigid
    Watson, Patrice
    Lynch, Jane F.
    Lynch, Henry T.
    Weisenburger, Dennis D.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 127 (01) : 31 - 38
  • [34] Fluorescence in situ hybridization in conjunction with karyotyping in detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia and its prognostic value
    Salam, M. Abdel
    El Sissy, A.
    Samra, M. A.
    Ibrahim, S.
    El Markalby, D.
    Gadallah, F.
    EJC SUPPLEMENTS, 2005, 3 (02): : 285 - 285
  • [35] Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia
    L Laurenti
    M Tarnani
    D G Efremov
    P Chiusolo
    L De Padua
    S Sica
    G Leone
    Leukemia, 2007, 21 : 1819 - 1821
  • [36] Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia
    Laurenti, L.
    Tarnani, M.
    Efremov, D. G.
    Chiusolo, P.
    De Padua, L.
    Sica, S.
    Leone, G.
    LEUKEMIA, 2007, 21 (08) : 1819 - 1821
  • [37] Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia
    Laurenti, L.
    Tarnani, M.
    Efremov, D. G.
    Fiorini, A.
    De Matteis, S.
    Chiusolo, P.
    De Padua, L.
    Innocenti, I.
    Sica, S.
    Leone, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 367 - 368
  • [38] SEQUENTIAL CHROMOSOME-ABNORMALITIES IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - A STUDY OF 13 CASES
    OHTAKI, K
    HAN, T
    SANDBERG, AA
    JAPANESE JOURNAL OF HUMAN GENETICS, 1986, 31 (02): : 234 - 235
  • [39] SEQUENTIAL CHROMOSOME-ABNORMALITIES IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - A STUDY OF 13 CASES
    OHTAKI, K
    HAN, T
    SANDBERG, AA
    CANCER GENETICS AND CYTOGENETICS, 1986, 20 (1-2) : 73 - 87
  • [40] Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia:: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation
    Karlsson, C.
    Norin, S.
    Kimby, E.
    Sander, B.
    MacDonald, A. Porwit
    Nilsson, B.
    Johansson, E.
    Mellstedt, H.
    Lundin, J.
    Osterborg, A.
    LEUKEMIA, 2006, 20 (12) : 2204 - 2007
12345